BCL2 and cancer: Twist1 can confer chemoresistance in different cancers by regulating several downstream signaling proteins, including mTOR and Bcl2. In addition, Twist1 binds and activates ABC transporters, mediates EMT-induced resistance, and positively regulates PI3K/AKT pathway (160).